肝癌合并肝动脉-门静脉瘘DSA表现及介入治疗分析  

DSA Manifestations and Interventional Treatment of Hepatocellular Carcinoma Complicated with Hepatic Portal Venous Fistula

作　　者：王诗学 WANG Shi-xue(Interventional Radiology Department,Xinyi People’s Hospital,Xinyi,Jiangsu Province,221400 China)

机构地区：[1]江苏省新沂市人民医院介入放射科,江苏新沂221400

出　　处：《中外医疗》2018年第4期188-189,192,共3页China & Foreign Medical Treatment

摘　　要：目的探讨原发性肝癌(PHC)合并肝动脉-门静脉瘘(HA-PVS)的DSA表现及介入治疗的临床效果。方法以2014年1月—2017年6月该院68例PHC合并HA-PVS患者为例,全部患者均行DSA检查及介入治疗,观察影像学表现及临床疗效。结果患者一次手术成功率98.53%,肿瘤客观缓解率54.41%,疾病控制率94.12%。结论 DSA能够为PHC合并HA-PVS的临床诊治提供有价值的影像学参考,针对性予以PHC合并HA-PVS介入治疗效果显著,值得推广使用。Objective This paper tries to investigate the DSA features of primary hepatic carcinoma(PHC)complicated with hepatic arterial portal venous fistula(HA-PVS)and the clinical effect of interventional therapy.Methods 68 cases of PHC with HA-PVS patients from January 2014 to June 2017 in this hospital were taken as the example,all patients underwent DSA examination and interventional treatment,the imaging performance and clinical efficacy were observed.Results The success rate was 98.53%,the tumor objective remission rate was 54.41%,and the disease control rate was 94.12%.Conclusion DSA can provide valuable imaging reference for clinical diagnosis and treatment of PHC combined with HA-PVS.Targeted interventional therapy with PHC combined with HA-PVS has significant effect and is worthy of popularization and application.

关 键 词：肝癌 肝动脉-门静脉瘘 DSA 介入治疗 

分 类 号：R735[医药卫生—肿瘤]